Nuclear Medicine and Molecular Imaging play pivotal roles in cancer research by offering precise diagnostic and therapeutic approaches. Utilizing radioactive tracers, these techniques allow visualization of cellular functions and molecular pathways, aiding in early detection and precise localization of tumors. Positron Emission Tomography (PET) scans, for instance, provide detailed metabolic information, assisting in treatment planning and monitoring tumor response to therapies. Additionally, targeted radionuclide therapies deliver radiation directly to cancer cells, minimizing damage to surrounding healthy tissue. The integration of advanced imaging modalities with molecular biology has revolutionized cancer management, facilitating personalized treatment strategies and improving patient outcomes. As research continues to evolve, the synergy between nuclear medicine and molecular imaging holds promise for further breakthroughs in cancer diagnosis, treatment, and prognosis.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States